publication venue for
- Increased incidence of diabetes in people living with HIV treated with first-line integrase strand transfer inhibitors: A French multicentre retrospective study 2024
- Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019. 705-716. 2022
- Epidemiological trends of HIV/HCV coinfection in Spain, 2015-2019.. 705-716. 2022
- Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort. 825-836. 2022
- Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort. BIS. 825-836. 2022
- COVID-19 in hospitalized HIV-positive and HIV- negative patients: A matched study. 867-876. 2021
- COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study. 867-876. 2021
- How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain. 128-134. 2020
- How well are we performing the initial assessment of HIV-positive patients? Results from a multicentre cohort in Spain 2019
- Decreasing rates of acute myocardial infarction in people living with HIV: a nationwide cohort study in Spain, 2004-2015 2018
- Genotypic tropism testing of proviral DNA to guide maraviroc initiation in aviraemic subjects: 48-week analysis of results from the PROTEST study. 482-489. 2017
- Biological markers of fertility (inhibin-B) in HIV-infectedd men: influence of HIV infecgtion and antiretroviral therapy. 436-444. 2016
- Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy. 653-661. 2016
- Relationship between plasma bilirubin level and oxidative stress markers in HIV-infected patients on atazanavir- vs. efavirenz-based antiretroviral therapy.. 653-661. 2016
- Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort. . 86-97. 2014
- Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir. . 330-338. 2014
- Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen.. 547-556. 2014
- Impact of vitamin D insufficiency on insulin homeostasis and beta cell function in nondiabetic male HIV-infected patients. 1-9. 2013
- Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in . 273-282. 2013
- Risk of clinically significant depression in HIV-infected patients: effect of antiretroviral drugs. . 1-5. 2013
- Switching from suppressive protease inhibitor based regimens to nevirapine based regimens: a meta-analysis of randomized controlled trials.. 747-756. 2013
- Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study. 488-498. 2012
- Inequalities in HIV disease management and progression in migrants from Latin America and sub-Saharan Africa living in Spain. 2012
- Considerations on ankle-brachial index.(ABI) interpretation in HIV-infected patients. 395-395. 2009